IVC Wealth Advisors LLC Has $292,000 Stock Position in The Clorox Company $CLX

IVC Wealth Advisors LLC lowered its position in shares of The Clorox Company (NYSE:CLX) by 3.6% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,433 shares of the company’s stock after selling 90 shares during the quarter. IVC Wealth Advisors LLC’s holdings in Clorox were worth $292,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in CLX. Wellington Management Group LLP increased its position in shares of Clorox by 18.8% during the 4th quarter. Wellington Management Group LLP now owns 4,074 shares of the company’s stock worth $662,000 after purchasing an additional 646 shares in the last quarter. NBC Securities Inc. increased its position in Clorox by 123,850.0% in the 1st quarter. NBC Securities Inc. now owns 2,479 shares of the company’s stock valued at $365,000 after acquiring an additional 2,477 shares in the last quarter. Merit Financial Group LLC increased its position in Clorox by 176.9% in the 1st quarter. Merit Financial Group LLC now owns 6,297 shares of the company’s stock valued at $927,000 after acquiring an additional 4,023 shares in the last quarter. RFG Advisory LLC increased its position in Clorox by 13.7% in the 1st quarter. RFG Advisory LLC now owns 2,406 shares of the company’s stock valued at $354,000 after acquiring an additional 290 shares in the last quarter. Finally, Hennion & Walsh Asset Management Inc. increased its position in Clorox by 56.2% in the 1st quarter. Hennion & Walsh Asset Management Inc. now owns 6,828 shares of the company’s stock valued at $1,005,000 after acquiring an additional 2,456 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insiders Place Their Bets

In related news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares of the company’s stock, valued at $6,711,475.38. This trade represents a 21.72% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.57% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on CLX shares. Zacks Research upgraded shares of Clorox from a “strong sell” rating to a “hold” rating in a research report on Monday, September 29th. Citigroup restated a “neutral” rating and issued a $135.00 price objective (down previously from $140.00) on shares of Clorox in a research report on Tuesday, July 15th. JPMorgan Chase & Co. raised their price objective on shares of Clorox from $133.00 to $135.00 and gave the company a “neutral” rating in a research report on Monday, September 8th. Jefferies Financial Group lowered their price objective on shares of Clorox from $167.00 to $145.00 and set a “buy” rating for the company in a research report on Thursday, June 26th. Finally, Wells Fargo & Company lowered their price objective on shares of Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a research report on Thursday, September 25th. One research analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, Clorox presently has a consensus rating of “Reduce” and an average target price of $134.08.

Clorox Stock Up 0.9%

Shares of NYSE CLX opened at $123.30 on Friday. The firm has a market capitalization of $15.08 billion, a PE ratio of 18.91, a price-to-earnings-growth ratio of 0.99 and a beta of 0.52. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The Clorox Company has a 1 year low of $116.53 and a 1 year high of $171.37. The firm’s 50-day moving average is $122.81 and its 200-day moving average is $129.53.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.63. The company had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter last year, the firm earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Equities analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be paid a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a yield of 4.0%. Clorox’s dividend payout ratio (DPR) is presently 76.07%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.